APA (7th ed.) Citation

Ping Li, Lin Wang, Zifei Tang, Yuhuan Wang, Zhanju Liu, Wensong Ge, & Ying Huang. (2024). Ustekinumab in pediatric patients with Crohn's disease: Safety, and efficacy results from a multicenter retrospective study in China. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Ping Li, Lin Wang, Zifei Tang, Yuhuan Wang, Zhanju Liu, Wensong Ge, and Ying Huang. Ustekinumab in Pediatric Patients with Crohn's Disease: Safety, and Efficacy Results from a Multicenter Retrospective Study in China. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Ping Li, et al. Ustekinumab in Pediatric Patients with Crohn's Disease: Safety, and Efficacy Results from a Multicenter Retrospective Study in China. Frontiers Media S.A., 2024.

Warning: These citations may not always be 100% accurate.